Addiction and obesity share deep neurological roots. Can new treatments like GLP-1 drugs and MEAI help break the cycle?

Over 13 weeks, adults with type 2 diabetes using an automated insulin delivery (AID) system had a 0.6-percentage point ...

A new study links semaglutide, the active ingredient in Ozempic and Wegovy, to a higher risk of hair loss, especially in ...

A WOMAN has left ht internet stunned after losing 8 stone in just 9 months with Mounjaro. Jess, from the UK, says she is so ...

Amneal Pharmaceuticals, Inc. offers strong growth prospects with undervalued stock, rising revenues, reduced debt, and key ...

Just ask Tom Brady—arguably the greatest quarterback of all time. He doesn’t have the sculpted physique of a bodybuilder, yet ...

Global Partners LP (NYSE:GLP) reported a revenue of $4.19 billion in Q4 of 2024, missing estimates by $1.62 billion. EPS was ...

Student scientists have developed an incredible new way to synthesize drugs on plants — and they're using Ozempic as their ...

For years, people taking GLP-1 type drugs (e.g., Ozempic, Wegovy) have noticed that the medicines didn’t just help them to ...

In this week’s edition of InnovationRx, we look at the policy uncertainty around vaccines, sex differences in GLP-1 drug side ...

Q3 2025 Results Conference Call March 19, 2025 9:00 AM ETCompany ParticipantsJeff Siemon - Vice President, Investor ...

Adults with insulin-treated type 2 diabetes had greater HbA1c reductions and larger improvement in time in range with use of ...